Themis Medicare Appoints Suresh Savaliya as Company Secretary; Approves Q1 FY27 Results
Themis Medicare Limited's Board approved Q1 FY27 Un-Audited Standalone and Consolidated Financial Results. The Board accepted the resignation of Mr. Nagraj Mogaveera as Interim Company Secretary & Compliance Officer and appointed Mr. Suresh Savaliya as the new Company Secretary, Compliance Officer, and KMP, both effective August 13, 2026.
The appointment of a new Company Secretary and Compliance Officer is a material event for corporate governance. The approval of quarterly financial results is also important, but the lack of specific financial performance figures limits the immediate impact assessment.
The announcement details financial results and changes in key management personnel. While the appointment of a new Company Secretary is a significant event, the financial results are noted without specific performance figures, and the resignation is for an internal role change, leading to a neutral sentiment.
Themis Medicare Limited announced the outcome of its Board Meeting held on August 13, 2026. The Board considered and approved the Un-Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, along with the Limited Review Reports from statutory auditors M/s. Krishaan & Co.
The meeting also noted and approved the resignation of Mr. Nagraj Mogaveera as Interim Company Secretary & Compliance Officer, effective August 13, 2026. Mr. Mogaveera is transitioning to a new role within the company as Deputy Manager – Secretarial Department. Subsequently, the Board approved the appointment of Mr. Suresh Savaliya as the Company Secretary, Compliance Officer, and Key Managerial Personnel (KMP) in place of Mr. Mogaveera, also effective August 13, 2026. Mr. Savaliya is a Qualified Company Secretary with 23 years of post-qualification experience in secretarial, corporate governance, and compliance matters, having previously worked with prominent companies like Reliance Industries Limited and Essel Group.
The Board meeting commenced at 10:30 A.M. (IST) and concluded at 12:45 P.M. (IST).
What to do with a filing like this
Themis Medicare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Themis Medicare Limited. Read the original for the full detail.